Gemcitabine-based vs. Non-gemcitabine Neoadjuvant Therapies in Liver Transplant for Cholangiocarcinoma: Institutional Insights

M. Abdelrahim; A. Esmail; J. Xu; A. Abudayyeh; B. Khasawneh; E. Al-Najjar

doi:10.1016/j.hpb.2025.07.152

Gemcitabine-based vs. Non-gemcitabine Neoadjuvant Therapies in Liver Transplant for Cholangiocarcinoma: Institutional Insights

M. Abdelrahim, A. Esmail, J. Xu, A. Abudayyeh, B. Khasawneh, E. Al-Najjar

Research output: Contribution to journal › Article › peer-review

Abstract

Background: We evaluate the outcomes of gemcitabine-based therapy versus non-gemcitabine-based therapy as neo-adjuvant therapy for orthotopic liver transplant (OLT) recipients with cholangiocarcinoma.

Original language	English (US)
Pages (from-to)	S308-S309
Journal	HPB
Volume	27
Early online date	Oct 3 2025
DOIs	https://doi.org/10.1016/j.hpb.2025.07.152
State	Published - Oct 3 2025

Divisions

Medical Oncology

Access to Document

10.1016/j.hpb.2025.07.152

Cite this

@article{83721d706f3d4afeb78cffa6b22a9429,

title = "Gemcitabine-based vs. Non-gemcitabine Neoadjuvant Therapies in Liver Transplant for Cholangiocarcinoma: Institutional Insights",

abstract = "Background: We evaluate the outcomes of gemcitabine-based therapy versus non-gemcitabine-based therapy as neo-adjuvant therapy for orthotopic liver transplant (OLT) recipients with cholangiocarcinoma.",

author = "M. Abdelrahim and A. Esmail and J. Xu and A. Abudayyeh and B. Khasawneh and E. Al-Najjar",

note = "doi: 10.1016/j.hpb.2025.07.152",

year = "2025",

month = oct,

day = "3",

doi = "10.1016/j.hpb.2025.07.152",

language = "English (US)",

volume = "27",

pages = "S308--S309",

journal = "HPB",

issn = "1365-182X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Gemcitabine-based vs. Non-gemcitabine Neoadjuvant Therapies in Liver Transplant for Cholangiocarcinoma: Institutional Insights

AU - Abdelrahim, M.

AU - Esmail, A.

AU - Xu, J.

AU - Abudayyeh, A.

AU - Khasawneh, B.

AU - Al-Najjar, E.

N1 - doi: 10.1016/j.hpb.2025.07.152

PY - 2025/10/3

Y1 - 2025/10/3

N2 - Background: We evaluate the outcomes of gemcitabine-based therapy versus non-gemcitabine-based therapy as neo-adjuvant therapy for orthotopic liver transplant (OLT) recipients with cholangiocarcinoma.

AB - Background: We evaluate the outcomes of gemcitabine-based therapy versus non-gemcitabine-based therapy as neo-adjuvant therapy for orthotopic liver transplant (OLT) recipients with cholangiocarcinoma.

U2 - 10.1016/j.hpb.2025.07.152

DO - 10.1016/j.hpb.2025.07.152

M3 - Article

SN - 1365-182X

VL - 27

SP - S308-S309

JO - HPB

JF - HPB

ER -

Gemcitabine-based vs. Non-gemcitabine Neoadjuvant Therapies in Liver Transplant for Cholangiocarcinoma: Institutional Insights

Abstract

Divisions

Access to Document

Fingerprint

Cite this